Low-dose ATG/PTCy for graft-versus-host disease prevention in haploidentical transplantation: influences of ATG doses and pre-ATG absolute lymphocyte count
Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Myeloid Neoplasms: A Systematic Review and Meta-Analysis
Post-Transplant-Cyclophosphamide and short-term Everolimus as Graft-versus-Host-Prophylaxis in a real –world cohort of patients with refractory T- and B-cell Lymphoma
High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: A LOC network study
Cardiac Events Occurring after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide. Study Conducted on Behalf of the GETH-TC
Ruxolitinib in Acute and Chronic Graft-Versus-Host Disease: Real Life Long-Term Experience in a Multi-Centre Study for Adult and Pediatric Patients, on Behalf of GETH-TC
Clinical Characteristics and Risk Factors for Clostridioides difficile Infection in the Hematopoietic Cell Transplantation Population
Hematopoietic Stem Cell Transplantation in Children with Mucopolysaccharidosis IVA: Single Center Experience
Incidence, Risk Factors and Therapy Response of Acute Graft-versus-Host Disease after Postransplant Cyclophosphamide
Pretransplantation risk factors for MRD after allogeneic stem cell transplantation in AML patients: A prospective study